Gene: Pik3ca
Official Full Name: phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alphaprovided by MGI
Gene Summary: Enables 1-phosphatidylinositol-3-kinase activity; insulin receptor substrate binding activity; and protein kinase activator activity. Involved in several processes, including cell surface receptor protein tyrosine kinase signaling pathway; cellular response to hydrostatic pressure; and phosphatidylinositol 3-kinase/protein kinase B signal transduction. Acts upstream of with a negative effect on autosome genomic imprinting. Acts upstream of or within several processes, including cellular response to glucose stimulus; negative regulation of apoptotic process; and regulation of macromolecule metabolic process. Located in intercalated disc and lamellipodium. Part of phosphatidylinositol 3-kinase complex. Is expressed in several structures, including early embryo; eye; and nervous system. Used to study CLOVES syndrome and breast cancer. Human ortholog(s) of this gene implicated in several diseases, including CLOVES syndrome; Cowden syndrome 5; breast cancer (multiple); cutaneous Paget's disease; and gastrointestinal system cancer (multiple). Orthologous to human PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha). [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01160 | Pik3ca Knockout cell line (EO771) | Mouse | Pik3ca | 1:2-1:4 | Negative | Online Inquiry |
Pik3ca Gene Knockout Cell Lines are genetically modified cell lines in which the Pik3ca gene, responsible for encoding the p110α catalytic subunit of phosphoinositide 3-kinase (PI3K), has been effectively inactivated. This innovative tool allows researchers to dissect the role of the PI3K/Akt signaling pathway, which is critically involved in various cellular processes, including growth, survival, and metabolism. By creating a knockout of the Pik3ca gene, these cell lines can be employed to study the downstream effects on cell behavior and their implications in oncogenesis, particularly in cancers where aberrant PI3K signaling is implicated.
The primary mechanism of action of these knockout cell lines revolves around the absence of p110α, leading to a reduction in PI3K pathway activity. This alteration enables scientists to understand the biological consequences of disrupting this key signaling pathway, including its influence on cell proliferation, apoptosis, and metabolic regulation. These studies are vital for elucidating the mechanisms of tumorigenesis and could guide the development of targeted therapies for cancer treatment.
Scientifically, Pik3ca Gene Knockout Cell Lines hold significant value in both research and clinical applications. They facilitate the examination of PI3K pathway involvement in diseases such as breast cancer, colorectal cancer, and other malignancies, making them indispensable for drug discovery and validation of therapeutic strategies. Additionally, their usage can help in identifying biomarkers for patient stratification and therapeutic response, thus enhancing personalized medicine approaches.
Compared to traditional cell models that may still possess functional Pik3ca genes, these knockout lines offer a more accurate representation of the loss-of-function scenario, allowing for clearer interpretations of experimental results. This specificity leads to a refinement in the research outcomes, providing more reliable data for downstream applications.
In conclusion, Pik3ca Gene Knockout Cell Lines represent a vital resource for researchers and clinicians aiming to explore the complexities of PI3K signaling in cancer biology. Our company specializes in state-of-the-art biological products, and we are committed to supporting the scientific community with high-quality tools that drive research forward and enhance understanding of crucial biological pathways.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.